Health technology is where software mistakes stop being abstract: the data is the most sensitive a business can hold, the regulator can classify your product as a medical device, and your customers — clinics, hospitals, NDIS providers, insurers — buy nothing without evidence you take that seriously. Here’s what technology leadership looks like for medical and health-tech businesses, and what a fractional CTO actually does in the sector.
Quick answer
A fractional CTO for a medical or health-tech business owns four things: health-grade data protection (Australian Privacy Principles and health-records law translated into architecture, not policy documents), regulatory positioning (knowing whether your software is heading into TGA software-as-a-medical-device territory before the regulator tells you), interoperability (FHIR/HL7 and the practical reality of integrating with clinical and practice-management systems), and sales-grade security evidence — because in health, security posture is a revenue function: hospitals, insurers and government buyers audit you before they buy.
The health data bar is higher — architecturally, not just legally
Health information is treated as sensitive information under the Privacy Act, with state health-records legislation layered on top. In practice that means:
- Consent and purpose limitation designed into the data model — who consented to what, recorded per record, enforced in code
- Access on a need-to-know basis with full audit trails — every access to a patient record attributable and reviewable; clinicians expect it, auditors require it
- Encryption, retention and deletion as system behaviours — health records carry long statutory retention in some contexts and hard deletion expectations in others; both are engineering requirements
- Breach readiness — notifiable data breach obligations mean detection, containment and communication paths must exist before the bad day
- De-identification done honestly — “we anonymised it” fails more diligence reviews than any other claim in health tech; re-identification risk is a real assessment, not a checkbox
If AI features touch patient data — increasingly the default — the boundary disciplines in our guide to AI/ML integration without data leaks apply at their strictest setting.
Know when you’re building a medical device
The TGA regulates software as a medical device (SaMD) — and the line is about what your software claims and does, not what you call it. Software that diagnoses, monitors, or influences clinical decisions can be captured; wellness and administrative software generally isn’t. The CTO’s job is to know which side of the line the roadmap sits on before features ship: classification determines quality-management expectations, clinical evidence requirements and change-control discipline. Getting this wrong in either direction is expensive — accidental capture is a compliance crisis; over-caution kills a roadmap that was actually fine.
Interoperability is where health-tech products live or die
Health software sells into an installed base: practice-management systems, clinical software, pathology feeds, Medicare and NDIS claiming, My Health Record. The modern standard is FHIR (with plenty of legacy HL7 v2 still in the field), and the practical realities matter more than the standard: integration partners with month-long onboarding queues, test environments that behave nothing like production, and data quality that varies wildly by source. Architecture that treats each integration as an adapter behind a canonical internal model — rather than letting each partner’s quirks leak through the codebase — is the difference between a platform and a pile of point integrations.
Security posture is a sales asset in health
Hospitals, insurers, aged-care groups and government health buyers send security questionnaires before contracts. A health-tech business that can answer with evidence — access-control model, audit logging, incident-response runbooks, penetration-test results, Essential Eight-aligned controls — closes deals its competitors stall on. This is a place where CTO and CISO responsibilities converge, and where a fractional leader who covers both saves an early-stage business from needing two hires. Our security & compliance service covers the posture work.
What a fractional CTO does for a medical or health-tech business
- Data and privacy architecture — consent, access, audit, retention designed correctly the first time
- Regulatory roadmap — SaMD positioning, quality processes proportionate to your classification
- Integration strategy — FHIR/HL7 architecture, partner sequencing, and honest effort estimates for the installed-base reality
- Security evidence — the posture and documentation that pass hospital and government procurement
- Team and vendor oversight — the senior review layer over developers and agencies building in a domain where mistakes are expensive
Health engagements run on the same published plans as all our work — see pricing and our HealthTech CTO Australia page, or start with how to hire a fractional CTO.
Frequently asked questions
Does our health-tech startup need TGA approval?
It depends on what the software claims and does — diagnosis, monitoring and clinical decision support can be captured as SaMD; administrative and general wellness software generally isn’t. Position this deliberately with regulatory advice; the CTO’s job is making sure the roadmap and the classification stay consistent.
Can we use cloud services and AI with patient data?
Yes, done properly: Australian-region processing where required, enterprise terms, minimisation and de-identification at boundaries, and access controls that survive an audit. What fails reviews is ad-hoc tooling nobody assessed.
What security certifications do health buyers actually ask for?
Expect questionnaires aligned to recognised frameworks, Essential Eight maturity questions from government-adjacent buyers, and increasingly ISO 27001 or SOC 2 for larger contracts. Start with real controls and evidence; certify when a deal justifies it.
Is this legal or regulatory advice?
No — it’s technology leadership guidance. Privacy and TGA decisions belong with your lawyers and regulatory consultants; we build the systems that make their advice true in production.